C
COLL icon

Covestor’s Collegium Pharmaceutical COLL Stock Holding History

Covestor’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10K Buy
282
+41
+17% +$1.4K 0.01% 1570
2026
Q1 		$8K Sell
241
-12
-5% -$508 0.01% 1543
2025
Q4 		$11K Sell
253
-9
-3% -$377 0.01% 1514
2025
Q3 		$9K Sell
262
-177
-40% -$6.15K 0.01% 1644
2025
Q2 		$13K Buy
439
+39
+10% +$1.11K 0.01% 1399
2025
Q1 		$12K Buy
400
+5
+1% +$153 0.01% 1386
2024
Q4 		$11K Buy
395
+22
+6% +$728 0.01% 1466
2024
Q3 		$14K Buy
373
+19
+5% +$678 0.01% 1354
2024
Q2 		$11K Buy
354
+13
+4% +$451 0.01% 1453
2024
Q1 		$13K Sell
341
-38
-10% -$1.33K 0.01% 1375
2023
Q4 		$12K Buy
379
+53
+16% +$1.33K 0.01% 1416
2023
Q3 		$8K Buy
326
+19
+6% +$433 0.01% 1531
2023
Q2 		$6K Buy
307
+264
+614% +$5.99K ﹤0.01% 1671
2023
Q1 		$1K Sell
43
-92
-68% -$2.44K ﹤0.01% 1829
2022
Q4 		$3K Sell
135
-120
-47% -$2.42K ﹤0.01% 1681
2022
Q3 		$4K Buy
255
+249
+4,150% +$4.39K ﹤0.01% 1534
2022
Q2 		$0 Sell
6
-26
-81% -$437 ﹤0.01% 1969
2022
Q1 		$1K Sell
32
-2
-6% -$38 ﹤0.01% 1761
2021
Q4 		$1K Buy
+34
New +$663 ﹤0.01% 1689

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Covestor's COLL Position: Q2 2026 in Review

Covestor increased its Collegium Pharmaceutical (COLL) stake by 17% in Q2 2026, buying an estimated $1.4K and bringing the position to 282 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1570.

Covestor first reported a position in COLL in Q4 2021 and has held it in 19 quarters since. The position peaked at $14K in Q3 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Covestor held 282 shares of Collegium Pharmaceutical worth $10K as of Q2 2026.
  • Covestor bought 41 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.4K.
  • Collegium Pharmaceutical made up 0.01% of Covestor's portfolio in Q2 2026, its #1570 holding.
  • Covestor first reported a position in Collegium Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Collegium Pharmaceutical position peaked at $14K in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.